Tomo, Jameson O.
HRN: 19-89-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
AMPICILLIN 500MG (VIAL)
06/01/2023
06/08/2023
IV
240mg
Q6
Multiple Aphthous Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes